Find information on thousands of medical conditions and prescription drugs.

Arthritis, Juvenile

Juvenile arthritis is a type of arthritis typically affects children before the age of sixteen. Most children with juvenile arthritis have a form of rheumatoid arthritis, the symptoms of which are identical to the adult kind. In many cases the condition is outgrown at a later age. Juvenile rheumatoid arthritis can occur as early as six weeks of age and occurs in girls more commonly than boys. There are three primary types of juvenile rheumatoid arthritis: Polyarticular, pauciarticular, and systemic. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines
  • Polyarticular involves more than five joints and may be associated with a low grade fever.
  • Pauciarticular, as the name implies, involves fewer joints (fewer than 4).
  • Systemic juvenile rheumatoid arthritis can affect the entire body.

High fevers may occur and tend to rise during the day and fall at night. Disease modifying antirheumatic drugs (DMARDS) may be able to slow the progression the disease. Newer medications such as anti-TNF alpha and anti-IL 1 drugs may also prove to be of significant help for juvenile rheumatoid arthritis.

Read more at Wikipedia.org


[List your site here Free!]


Severe diffusion capacity reduction in a case of systemic onset juvenile rheumatoid arthritis with mild pulmonary hypertension
From CHEST, 10/1/05 by Paul K. Nolan

INTRODUCTION: Pulmonary Artery Hypertension (PAH) with severe diffusion capacity (DLCO) reduction complicating Systemic Onset Juvenile Rheumatoid (SOJRA) is extremely rare, only one case being reported. (1) In children with JRA, Pulmonary Function Tests (PFT) rarely show DLCO impairment and if present is usually only to a mild to moderate. (2) We describe a case of SOJRA complicated by a severely reduced DLCO with mild PAH.

CASE PRESENTATION: A 13 year old female with SOJRA and partial Macrophage Activation Syndrome (MAS) developed dyspnea and tachycardia during the 5th month of active disease. During the 9th month, she experienced a life threatening MAS episode. PFT showed hypoxia and severe hemoglobin (hgb) corrected DLCO at 24% without obstruction or restriction. High Resolution Chest CT with angiography and Ventilation Perfusion scan showed no interstitial pulmonary fibrosis or macrovascular thromboembolism. Despite aggressive immunosuppressive therapy with pulsed methylprednisolone, cyclosporine A and methotrexate, the patient's dyspnea and hypoxia worsened. Heart catheterization at month 13 demonstrated mild PAH with mean pulmonary artery pressure (mPAP) of 37 mm Hg without intrapulmonary or significant intracardiac shunting. Bosentan was started in month 14. The patient experienced a second life threatening MAS episode in month 15. Etoposide was instituted to suppress the activated macrophages, which was followed by rapid clinical improvement in the MAS. Open lung biopsy at month 16 showed changes onlight microscopy (LM) of preplexogenic pulmonary hypertension with intimal thickening and on electron microscopy (EM), multilamellated thickening of the alveolar capillary basement membrane (BM). There was no evidence of pulmonary fibrosis or thrombosis. The patient's hgb DLCO reached it's nadir of 21% by month 16 and has improved to 52 % by month 21. Repeat heart cath at month 18 showed normalization of the mPAP at 25 mm Hg.

DISCUSSIONS: The severe hypoxia and diffusion capacity limitation described were markedly out of proportion to degree of PAH found. The etiology of the hypoxia is the ultramicroscopic structural changes at the level of the alveolar capillary endothelium. Similar pathologic microvascular endotheliopathy lesions have been described on electron microscopic of the pulmonary alveolar capillary basement membrane in patients with plexogenic primary pulmonary hypertension. (3) The likely pathologic cascade that led to these BM changes was likely excess release of endothelin-1 and cytokines from the activated macrophages, which triggered further endothelin-1 synthesis and release from the vascular endothelium. (4,5,6).

CONCLUSION: PAH and pulmonary microvascular endotheliopathy should be suspected when hypoxia and DLCO reduction are present in systemic rheumatologic disease. Early lung biopsy with LM and EM should be pursued to allow expeditious implementation of potentially life saving medications before irreversible pathology develops in the lungs.

[GRAPHIC OMITTED]

REFERENCES:

(1) Padeh S, Laxer RM, Silver MM, Silverman ED. "Primary Pulmonary Hypertension in a patient with Systemic-Onset Juvenile Arthritis." Arthritis Rheuma 1991; 34(12):1575-79.2.

(2) Pelucchi A, Lomater C, Gerloni V, Foresi A, Fantini F, Marazzini L. "Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy." Clin Exp Rheuma

(3) Villaschi S, Pietra GG. "Alveolo-capillary membrane in primary pulmonary hypertension." Appl Pathol. 1986;4(3):132-7.

(4) Li Z, Niwa Y, Rokutan K, Nakaya Y. "Expression of endothelin-1 in macrophages and mast cells in hyperplastic human tonsils." FEBS Lett. 1999 Sep 3;457(3):381-4.

(5) Molet S, Furukawa K, Maghazechi A, et al. "Chemokine and cytokine induced expression of endothelin 1 and endothelin converting enzyme 1 in endothelial cells. J Allergy Clin Immunol 2000; 105:333-8.

(6) Simonson MS, Herman WH, Knauss TC, Schulak JA, Hricik DE." Macrophages-but not T-cell-derived cytokines stimulate endothelin-1 secretion by endothelial cells" Transplant Proc. 1999 Feb-Mar; 31(1-2):806-7.

DISCLOSURE: Paul Nolan, None.

Paul K. Nolan MD * Curt Daniels MD Fredrick Long MD Megan K. Dishop MD Peter Baker MD Margarita Guarin MD Elizabeth D. Allen MD Robert Rennenbohm MD Columbus Children's Hospital, Columbus, OH

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Arthritis, Juvenile
Home Contact Resources Exchange Links ebay